This website google translation is automatic. Our information refers to health and other services in the UK. Before changing any care or treatment, please talk to your doctor about what you have read here. We hope you find the translated pages useful.
News
News
When SMA hits the headlines: Holding space for parents and adults in our community
Advocacy
News
Newborn screening for SMA: a short overview
Advocacy
Information
News
Reflecting on recent news shared by Jesy Nelson
Advocacy
Information
News
Treatments & Research
UK Drug Deal with the US and Changes to NHS Medicine Costs
Advocacy
News
Treatments & Research
Celebrating Mark Dearlove’s leadership and Welcoming Our New Chair of Trustees
News
Making Care Better: SMA UK’s Fight for Change
News
Itvisma from Novartis, a new, safer way of administering gene therapy for older children and adults living with SMA
News
Uncategorized
Update on NICE Decision for Continued Access to risdiplam (Evrysdi) and nusinersen (Spinraza).
News
Treatments & Research
First NICE committee meeting for continued access to Spinraza and Risdiplam
Advocacy
News
The Power of Real-World Data: Why Patients’ Experiences Prove the Case for SMA Drugs